John Taylor: Public Servant Extraordinaire

  • by: |
  • 12/13/2013

From: A Message from the Commissioner

Sent: Wednesday, December 11, 2013 02:05 PM

To: FDA-Wide

Subject: Personnel Announcement

Dear Colleagues:

I am deeply saddened to announce that John M. Taylor, Counselor to the Commissioner and Acting Deputy Commissioner for Global Regulatory Operations and Policy (GO), will be leaving the Food and Drug Administration in January 2014 to pursue other opportunities.  John has accomplished so much during his two stints at the Agency (from 1991 to 2005 and from 2009 to present) as he served in various ways and touched many lives.  From his early days in the Office of Chief Counsel, to his senior roles in the Center for Drug Evaluation and Research, the Office of Regulatory Affairs, and the Office of the Commissioner, John has brought leadership, sound advice, and most of all, good humor to his work.  We will all miss his expert knowledge, his innovative thinking, and his uncanny ability to remain calm during times of adversity and matters of urgency.  John has proven himself as a leader who epitomizes integrity, dignity, kindness and compassion, and he is widely respected by his colleagues.

Most recently, John has been wearing two hats – Counselor to the Commissioner and Acting Deputy Commissioner for GO.  In these two positions over the past year, John has demonstrated flexibility, creativity, and decisiveness that has enabled us to make important forward progress on key matters.  John has always stepped up in the times when I have needed him most to take on specific tasks that represent my highest priorities, including those related to globalization, FDASIA, and pharmacy compounding.  John has been a catalyst for organizational progress and change while handling and managing the high demands of the Office of the Commissioner.  And notably, John agreed to serve as the Acting Principal Deputy Commissioner during a time when the Agency was in a period of transition, for which I am extremely grateful.

 I know I speak for all of us when I say that John will be sorely missed.  Please join me in thanking him for his distinguished service to FDA and wishing him the very best in his future endeavors.

Margaret A. Hamburg, M.D.
Commissioner of Food and Drugs


Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
Better Health
Biotech Blog
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
Envisioning 2.0
FDA Law Blog
Fierce Pharma
Fresh Air Fund
Furious Seasons
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
In the Pipeline
In Vivo
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
More than Medicine
National Review
Neuroethics & Law
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmacology Corner
Pharmaceutical Business Review
Piper Report
Prescription for a Cure
Public Plan Facts
Real Clear Politics
Shark Report
Shearlings Got Plowed
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog